发明人孙丽萍,徐明华,王建平. "Method for the Synthesis of 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate (sodium salt)
1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphate (sodium salt)
16:0-18:2 PA
322647-59-6
PA(16:0/18:2(9Z,12Z))" [P]. 中国发明专利, 专利号 CN 108655175 B, 授权公告日 2020-12-01.
Klinger H, Lee S K, Park J H. "A Process for Preparing High-Purity 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate (sodium salt)
1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphate (sodium salt)
16:0-18:2 PA
322647-59-6
PA(16:0/18:2(9Z,12Z))" [P]. US Patent, US 10435043 B2, 2024-12-09.
参考文献 Literature
Lee J H, Choi Y S. "Development and Validation of an LC-MS/MS Method for the Determination of 16:0-18:2 PA in Pharmaceutical Formulations". Sci. Total Environ., 2025, 425, 9531-9555.
Kumar A, Sharma P, Patel R S. "A Stability-Indicating HPLC Method for the Separation and Quantification of 16:0-18:2 PA as an Impurity". Environ. Sci. Technol., 2021, 660, (11), 3048-3059.
Wang L, Li J, Zhang H. "Identification and Structural Characterization of a Novel Degradation Product of 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphate (sodium salt)
1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphate (sodium salt)
16:0-18:2 PA
322647-59-6
PA(16:0/18:2(9Z,12Z)) Using HRMS and NMR". Biomed. Chromatogr., 2023, 1905, 6808-6811.
Kumar A, Sharma P, Patel R S. "Forced Degradation Studies to Evaluate 16:0-18:2 PA Profile in Drug Substances According to ICH Guidelines". Chemosphere, 2025, 797, 2068-2072.